These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22514213)

  • 21. The Lorenzini Foundation in a changing scenario of patient management.
    Peracino A; Paoletti R
    Atheroscler Suppl; 2009 Jun; 10(1):22-8. PubMed ID: 19497554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ageing, lifestyle modifications, and cardiovascular disease in developing countries.
    Dominguez LJ; Galioto A; Ferlisi A; Pineo A; Putignano E; Belvedere M; Costanza G; Barbagallo M
    J Nutr Health Aging; 2006; 10(2):143-9. PubMed ID: 16554951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.
    Gersh BJ; Sliwa K; Mayosi BM; Yusuf S
    Eur Heart J; 2010 Mar; 31(6):642-8. PubMed ID: 20176800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance measures in million hearts: 2 partners' perspective.
    Drozda JP; Holmes DP
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):587-8. PubMed ID: 22811502
    [No Abstract]   [Full Text] [Related]  

  • 25. Projecting the probability of survival free from cancer and cardiovascular incidence through lifestyle modification in Japan.
    Tanaka S; Yamamoto S; Inoue M; Iwasaki M; Sasazuki S; Iso H; Tsugane S;
    Prev Med; 2009 Feb; 48(2):128-33. PubMed ID: 19071158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Worldwide Exposures to Cardiovascular Risk Factors and Associated Health Effects: Current Knowledge and Data Gaps.
    Tzoulaki I; Elliott P; Kontis V; Ezzati M
    Circulation; 2016 Jun; 133(23):2314-33. PubMed ID: 27267538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CVD Prevention Through Policy: a Review of Mass Media, Food/Menu Labeling, Taxation/Subsidies, Built Environment, School Procurement, Worksite Wellness, and Marketing Standards to Improve Diet.
    Afshin A; Penalvo J; Del Gobbo L; Kashaf M; Micha R; Morrish K; Pearson-Stuttard J; Rehm C; Shangguan S; Smith JD; Mozaffarian D
    Curr Cardiol Rep; 2015 Nov; 17(11):98. PubMed ID: 26370554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primordial prevention of cardiovascular disease risk in The Netherlands.
    Kromhout D
    Prev Med; 1999 Dec; 29(6 Pt 2):S106-10. PubMed ID: 10641827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart healthy and stroke free: successful business strategies to prevent cardiovascular disease.
    Matson Koffman DM; Goetzel RZ; Anwuri VV; Shore KK; Orenstein D; LaPier T
    Am J Prev Med; 2005 Dec; 29(5 Suppl 1):113-21. PubMed ID: 16389136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Socioeconomic considerations in the primordial prevention of cardiovascular disease.
    Kaplan GA; Lynch JW
    Prev Med; 1999 Dec; 29(6 Pt 2):S30-5. PubMed ID: 10641815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges for the management of hypertension in low-resource settings.
    Mendis S
    Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of cardiovascular disease risk amongst the population eligible for the NHS Health Check Programme.
    Dalton AR; Soljak M; Samarasundera E; Millett C; Majeed A
    Eur J Prev Cardiol; 2013 Feb; 20(1):142-50. PubMed ID: 22058079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Health behaviours among men age > 50 years with reference to risk factors cardiovascular diseases].
    Jóźwiak P; Szmagaj A
    Przegl Lek; 2012; 69(10):934-9. PubMed ID: 23421064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Worksite and Community Health Promotion/Risk Reduction Project--Virginia, 1987-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Jan; 41(4):55-7. PubMed ID: 1731183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing the cardiovascular disease burden: justified means for getting to the end.
    Bikdeli B; Barreto-Filho JA
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):580-6. PubMed ID: 22811501
    [No Abstract]   [Full Text] [Related]  

  • 38. [Health policy interventions: the pathway to public health].
    Andersen K; Gudnason V
    Laeknabladid; 2013 Mar; 99(3):129-34. PubMed ID: 23486685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease.
    Emberson J; Whincup P; Morris R; Walker M; Ebrahim S
    Eur Heart J; 2004 Mar; 25(6):484-91. PubMed ID: 15039128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of modifiable cardiovascular risk factors in German adolescents.
    Müller-Riemenschneider F; Nocon M; Willich SN
    Eur J Cardiovasc Prev Rehabil; 2010 Apr; 17(2):204-10. PubMed ID: 19996972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.